Company Gets 510(k) for Extracellular Matrix Product

Kensey Nash received 510(k) clearance from the FDA for its Medeor Matrix, a porcine-based dermal extracellular matrix that acts as a biologic scaffold for tissue growth, according to a company statement. The product will be used to reinforce and repair soft tissue in hernia repair and plastic and reconstructive surgery. The company plans to market the product in the second half of this fiscal year.